CervoMed CRVO
NASDAQ CRVO
$3.02 +0.09 (+3.07%)
At close: Oct 2, 2026 · 4:00 PM EDT

CervoMed (CRVO) Change in Accured Expenses (2010 - 2026)

Updated

CervoMed (CRVO) recorded Change in Accured Expenses of -$119,157 in Q2 2026, compared with $713,608 a year earlier.

Analysis

CervoMed (CRVO) Change in Accured Expenses (2010 - 2026) Analysis & Trends

On a TTM basis, CervoMed's Change in Accured Expenses came in at -$810,462 as of Jun 30, 2026; for FY2025, it was $834,157, up 20.8% from FY2024.

  • Annual Change in Accured Expenses has a five-year compound annual growth rate of -2.6% (FY2020 to FY2025).
  • Across earlier years, Change in Accured Expenses came in at $690,290 in FY2024 (-46.4%), $1.29 million in FY2023 (+497.7%), $215,679 in FY2022 (-64.4%) and $605,370 in FY2021 (-36.3%).
  • Quarterly Change in Accured Expenses has ranged from -$1.1 million in Q1 2026 to $1.09 million in Q3 2024 over the past five years.
  • Peak year-over-year performance for Change in Accured Expenses in the last five years was growth of 272.6% in Q4 2023, against a decline of 65.4% in Q4 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at -$1.1 million (Q1 2026), -$48,096 (Q4 2025) and $454,084 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 2.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 338.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 CervoMed 30.94 Mn 30.94 Mn - -119,157.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -119,157.00
Mar 31, 2026 -1.10 Mn
Dec 31, 2025 -48,096.00
Sep 30, 2025 454,084.00
Jun 30, 2025 713,608.00
Mar 31, 2025 -285,439.00
Dec 31, 2024 203,906.00
Sep 30, 2024 1.09 Mn
Jun 30, 2024 -335,860.00
Mar 31, 2024 -268,696.00
Dec 31, 2023 590,016.00
Sep 30, 2023 672,931.00
Jun 30, 2023 -338,730.00
Mar 31, 2023 364,807.00
Dec 31, 2022 158,332.00
Sep 30, 2022 470,009.00
Jun 30, 2022 -440,808.00
Mar 31, 2022 28,146.00
Dec 31, 2021 246,667.00
Sep 30, 2021 676,279.00
API Access

CervoMed Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=CRVO&period=max&api_key=YOUR_API_KEY